Michael Pine - Net Worth and Insider Trading
Michael Pine Net Worth
The estimated net worth of Michael Pine is at least $3,920 dollars as of 2024-11-13. Michael Pine is the Senior Officer of Medexus Pharmaceuticals Inc and owns about 2,000 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $3,920. Details can be seen in Michael Pine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Pine has not made any transactions after 2021-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Pine
Michael Pine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Pine owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .
Click here to see the complete history of Michael Pine’s form 4 insider trades.
Insider Ownership Summary of Michael Pine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-08-19 | Senior Officer |
Michael Pine Latest Holdings Summary
Michael Pine currently owns a total of 1 stock. Michael Pine owns 2,000 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of August 19, 2021, with a value of $3,920.
Latest Holdings of Michael Pine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-08-19 | 2,000 | 1.96 | 3,920 |
Holding Weightings of Michael Pine
Michael Pine Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Pine has made a total of 3 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 500 shares on August 19, 2021, which cost Michael Pine around $1,438.
Insider Trading History of Michael Pine
- 1
Michael Pine Trading Performance
GuruFocus tracks the stock performance after each of Michael Pine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Pine is -18.98%. GuruFocus also compares Michael Pine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Pine within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Pine's insider trading performs compared to the benchmark.
Performance of Michael Pine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.18 | | | | | |
| Relative Return to S&P 500(%) | 3.17 | | | | | |
Michael Pine Ownership Network
Ownership Network List of Michael Pine
Ownership Network Relation of Michael Pine
Michael Pine Owned Company Details
What does Medexus Pharmaceuticals Inc do?
Who are the key executives at Medexus Pharmaceuticals Inc?
Michael Pine is the Senior Officer of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Brendon Buschman , Director & Senior Officer Kenneth d'Entremont , and Senior Officer Marcel Pascal Konrad .
Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary
Over the past 18 months, Michael Pine made no insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP). Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 20,000 shares made by Brendon Buschman , a net purchase of 7,000 shares made by Mike Mueller , and a net purchase of 18,800 shares made by Kenneth d'Entremont .
In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 147,900 shares were bought by its insiders, resulting in a net purchase of 147,900 shares.
Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medexus Pharmaceuticals Inc Insider Transactions
Michael Pine Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Pine. Currently GuruFocus does not have mailing address information for Michael Pine.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
